Home » Paola Roldán, the woman with ALS who managed to legalize euthanasia in Ecuador, dies

Paola Roldán, the woman with ALS who managed to legalize euthanasia in Ecuador, dies

by admin
Paola Roldán, the woman with ALS who managed to legalize euthanasia in Ecuador, dies

Paola Roldán, a fierce advocate for the legalization of euthanasia in Ecuador, passed away on Monday in Quito. Paola, who had been battling amyotrophic lateral sclerosis (ALS) for over three years, saw her efforts come to fruition when the Constitutional Court declared the right to request assisted death for those suffering from serious and incurable illnesses. This landmark decision not only granted Paola the freedom to end her life on her terms but also inspired hope for other patients in similar situations throughout Latin America.

Despite her deteriorating health and intense pain, Paola continued to fight for the rights of ALS patients till her last breath. She not only envisioned a better future for herself but also worked towards creating a network of psychological support for ALS patients and their families. This initiative aimed to provide much-needed assistance and care to those coping with the challenges of the disease, which often comes with significant financial burdens.

Paola’s unwavering determination and resilience in the face of adversity have left a lasting impact on those who knew her. Her legacy will live on through the support network she helped establish and the lives she touched along the way. As she once said, “even in true struggles, life must be celebrated,” a sentiment that resonates deeply in the hearts of all who had the privilege of knowing Paola Roldán.

As we bid farewell to a courageous advocate and champion of life, let us remember Paola’s spirit and determination to make a difference in the world. Her legacy will continue to inspire us to fight for what we believe in and to cherish every moment we have. Rest in peace, Paola Roldán. Your impact will never be forgotten.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy